Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/04/17
End: 03/20/19
Due: 03/20/20
Phase: N/A
Priority: Normal
Start: 07/05/17
End: 10/11/18
Due: 10/11/19
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 03/31/17
Due: 03/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy | NCT03242265 | ATGen Canada Inc | user2@example.com | None | 2017-04-04 | 2019-03-20 | 2020-03-20 | - | - | 2025-07-14 |
| Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy | NCT03249727 | ATGen Canada Inc | user2@example.com | None | 2017-07-05 | 2018-10-11 | 2019-10-11 | - | - | 2025-07-14 |
| Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy | NCT02291198 | ATGen Canada Inc | user2@example.com | None | 2014-10-31 | 2017-03-31 | 2018-03-31 | - | - | 2025-07-14 |